Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 26 | 2017 | 42 | 7.760 |
Why?
|
| alpha-Synuclein | 15 | 2017 | 17 | 4.460 |
Why?
|
| Disease Models, Animal | 15 | 2017 | 98 | 2.380 |
Why?
|
| Animals | 36 | 2017 | 735 | 2.110 |
Why?
|
| Dopaminergic Neurons | 6 | 2017 | 6 | 1.750 |
Why?
|
| Brain | 8 | 2017 | 92 | 1.610 |
Why?
|
| Humans | 33 | 2017 | 1892 | 1.450 |
Why?
|
| Neurons | 12 | 2017 | 42 | 1.420 |
Why?
|
| Nerve Degeneration | 5 | 2017 | 5 | 1.420 |
Why?
|
| Aging | 7 | 2017 | 75 | 1.210 |
Why?
|
| Multiple System Atrophy | 3 | 2017 | 3 | 1.140 |
Why?
|
| Neurodegenerative Diseases | 5 | 2016 | 16 | 1.090 |
Why?
|
| Antiparkinson Agents | 2 | 2017 | 3 | 1.010 |
Why?
|
| Genetic Therapy | 4 | 2015 | 16 | 0.850 |
Why?
|
| Brain Tissue Transplantation | 3 | 2012 | 5 | 0.770 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 3 | 0.710 |
Why?
|
| Lewy Bodies | 4 | 2016 | 10 | 0.680 |
Why?
|
| Huntington Disease | 4 | 2014 | 6 | 0.580 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 11 | 0.560 |
Why?
|
| Oligodendroglia | 1 | 2017 | 1 | 0.540 |
Why?
|
| Cryopreservation | 1 | 2017 | 2 | 0.540 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 2 | 0.540 |
Why?
|
| Primates | 1 | 2017 | 1 | 0.530 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2017 | 1 | 0.530 |
Why?
|
| Levodopa | 1 | 2017 | 3 | 0.530 |
Why?
|
| Female | 15 | 2017 | 971 | 0.520 |
Why?
|
| Substantia Nigra | 7 | 2017 | 8 | 0.520 |
Why?
|
| Lewy Body Disease | 1 | 2015 | 4 | 0.480 |
Why?
|
| Male | 14 | 2017 | 1041 | 0.470 |
Why?
|
| Stem Cells | 1 | 2014 | 3 | 0.440 |
Why?
|
| Tissue Extracts | 1 | 2014 | 1 | 0.440 |
Why?
|
| Dopamine | 6 | 2017 | 13 | 0.430 |
Why?
|
| Cell Transplantation | 2 | 2011 | 2 | 0.420 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 9 | 0.420 |
Why?
|
| Colon | 1 | 2013 | 1 | 0.420 |
Why?
|
| Antibodies | 1 | 2013 | 10 | 0.390 |
Why?
|
| Corpus Striatum | 6 | 2017 | 10 | 0.390 |
Why?
|
| Macaca mulatta | 9 | 2017 | 9 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2017 | 94 | 0.380 |
Why?
|
| Transplants | 1 | 2012 | 1 | 0.370 |
Why?
|
| Hydrogels | 1 | 2009 | 4 | 0.310 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 2 | 0.310 |
Why?
|
| Neurosciences | 1 | 2009 | 2 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 9 | 0.310 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 8 | 0.310 |
Why?
|
| Dependovirus | 4 | 2017 | 9 | 0.290 |
Why?
|
| Tyrosine 3-Monooxygenase | 5 | 2015 | 6 | 0.270 |
Why?
|
| Mice | 7 | 2016 | 209 | 0.250 |
Why?
|
| Rats | 4 | 2017 | 155 | 0.250 |
Why?
|
| Neurogenesis | 2 | 2017 | 2 | 0.230 |
Why?
|
| History, 20th Century | 3 | 2017 | 4 | 0.210 |
Why?
|
| Parkinsonian Disorders | 2 | 2015 | 8 | 0.190 |
Why?
|
| Genetic Vectors | 3 | 2017 | 9 | 0.180 |
Why?
|
| Mesencephalon | 3 | 2017 | 3 | 0.180 |
Why?
|
| Time Factors | 2 | 2013 | 143 | 0.180 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 18 | 0.170 |
Why?
|
| Microglia | 2 | 2017 | 6 | 0.160 |
Why?
|
| Congresses as Topic | 2 | 2016 | 7 | 0.160 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 17 | 0.160 |
Why?
|
| Cell Line | 2 | 2017 | 43 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 52 | 0.150 |
Why?
|
| Mitochondria | 2 | 2016 | 10 | 0.150 |
Why?
|
| Endopeptidase K | 1 | 2017 | 1 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 2 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2017 | 6 | 0.130 |
Why?
|
| Haplorhini | 1 | 2017 | 2 | 0.130 |
Why?
|
| Astrocytes | 1 | 2017 | 5 | 0.130 |
Why?
|
| History, 21st Century | 2 | 2017 | 4 | 0.130 |
Why?
|
| Pyruvic Acid | 1 | 2016 | 1 | 0.130 |
Why?
|
| Autophagy | 1 | 2016 | 3 | 0.130 |
Why?
|
| Axons | 1 | 2016 | 1 | 0.130 |
Why?
|
| Colon, Sigmoid | 1 | 2016 | 2 | 0.130 |
Why?
|
| Inflammation | 1 | 2016 | 17 | 0.130 |
Why?
|
| Pyridines | 2 | 2016 | 9 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 1 | 0.120 |
Why?
|
| Disease Progression | 2 | 2013 | 43 | 0.120 |
Why?
|
| Graft Survival | 3 | 2014 | 8 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2011 | 31 | 0.120 |
Why?
|
| Ataxin-1 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Cerebellar Nuclei | 1 | 2015 | 1 | 0.120 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2015 | 1 | 0.120 |
Why?
|
| RNA Interference | 1 | 2015 | 4 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 6 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2015 | 33 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2015 | 22 | 0.120 |
Why?
|
| Neurturin | 1 | 2015 | 2 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2012 | 2 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 7 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 5 | 2015 | 27 | 0.120 |
Why?
|
| Peptides | 1 | 2015 | 16 | 0.110 |
Why?
|
| Behavior, Animal | 2 | 2016 | 8 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2014 | 1 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 1 | 0.110 |
Why?
|
| Heterografts | 1 | 2014 | 1 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2014 | 4 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2013 | 1 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 2 | 0.110 |
Why?
|
| Vagus Nerve | 1 | 2013 | 3 | 0.100 |
Why?
|
| Permeability | 1 | 2013 | 9 | 0.100 |
Why?
|
| Gastrointestinal Agents | 1 | 2013 | 2 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 18 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 59 | 0.100 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2013 | 1 | 0.100 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 3 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2013 | 3 | 0.100 |
Why?
|
| Protein Folding | 1 | 2013 | 2 | 0.100 |
Why?
|
| Protein Engineering | 1 | 2013 | 3 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 14 | 0.100 |
Why?
|
| Morpholines | 1 | 2012 | 1 | 0.100 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2012 | 1 | 0.100 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 8 | 0.100 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 9 | 0.100 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 25 | 0.100 |
Why?
|
| Neurobiology | 1 | 2012 | 1 | 0.100 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 1 | 0.090 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2012 | 2 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 3 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 1 | 0.090 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2011 | 1 | 0.090 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 1 | 0.090 |
Why?
|
| Adrenergic Neurons | 1 | 2011 | 1 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2011 | 4 | 0.090 |
Why?
|
| Middle Aged | 4 | 2016 | 488 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 2 | 0.090 |
Why?
|
| Risk Factors | 1 | 2011 | 140 | 0.080 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2010 | 1 | 0.080 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 1 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2010 | 4 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 10 | 0.080 |
Why?
|
| Aged | 3 | 2016 | 414 | 0.080 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Enzyme Therapy | 1 | 2010 | 1 | 0.080 |
Why?
|
| Enzymes | 1 | 2010 | 2 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2010 | 4 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 80 | 0.080 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2009 | 1 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 26 | 0.080 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2009 | 1 | 0.080 |
Why?
|
| Quinolinic Acid | 1 | 2009 | 1 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2009 | 5 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2009 | 4 | 0.080 |
Why?
|
| Environment | 1 | 2009 | 2 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 1 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2008 | 3 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 7 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 4 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2014 | 10 | 0.070 |
Why?
|
| Biopsy | 2 | 2016 | 11 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2015 | 88 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2016 | 72 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2014 | 3 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2014 | 3 | 0.050 |
Why?
|
| Papio | 2 | 2013 | 3 | 0.050 |
Why?
|
| Huntingtin Protein | 2 | 2014 | 4 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 15 | 0.050 |
Why?
|
| Cell Survival | 2 | 2011 | 13 | 0.040 |
Why?
|
| Synaptophysin | 2 | 2009 | 2 | 0.040 |
Why?
|
| Age Factors | 2 | 2009 | 51 | 0.040 |
Why?
|
| Anniversaries and Special Events | 1 | 2017 | 1 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2017 | 1 | 0.030 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2016 | 1 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 1 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 3 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 3 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 22 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 9 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2015 | 1 | 0.030 |
Why?
|
| Thalamus | 1 | 2015 | 2 | 0.030 |
Why?
|
| Brain Stem | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 3 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2015 | 1 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 2 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 10 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2015 | 5 | 0.030 |
Why?
|
| CCAAT-Binding Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
| Chemokine CCL11 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 5 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 18 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 209 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 1 | 0.030 |
Why?
|
| Animals, Outbred Strains | 1 | 2014 | 1 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Radioactive Tracers | 1 | 2013 | 1 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 3 | 0.020 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2012 | 1 | 0.020 |
Why?
|
| Propylamines | 1 | 2012 | 1 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 59 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 99 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 3 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 2 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 4 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 44 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2010 | 1 | 0.020 |
Why?
|
| NADPH Dehydrogenase | 1 | 2010 | 1 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2010 | 1 | 0.020 |
Why?
|
| Silver Staining | 1 | 2010 | 1 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2010 | 1 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 5 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2010 | 5 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 9 | 0.020 |
Why?
|
| tau Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Axonal Transport | 1 | 2010 | 1 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 6 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 7 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 27 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 63 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 4 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 12 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 36 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 38 | 0.020 |
Why?
|
| Hippocampus | 1 | 2009 | 19 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 1 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2009 | 2 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 2 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 4 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2009 | 2 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 7 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2009 | 5 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 10 | 0.020 |
Why?
|
| Autopsy | 1 | 2009 | 12 | 0.020 |
Why?
|
| Oleanolic Acid | 1 | 2009 | 1 | 0.020 |
Why?
|
| Neocortex | 1 | 2009 | 1 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2008 | 5 | 0.020 |
Why?
|
| Cats | 1 | 2008 | 6 | 0.020 |
Why?
|
| Child | 1 | 2008 | 156 | 0.020 |
Why?
|
| Adult | 1 | 2008 | 551 | 0.020 |
Why?
|